Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...
Spectrum Health is one of the first hospitals in Michigan to offer a novel treatment for emphysema. The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the publication of long ...
REDWOOD CITY, California, December 10, 2018 - Pulmonx, a leader in interventional pulmonary device technology announced today that the National Institute for Health and Care Excellence (NICE) in the ...
Pulmonx, a leader in interventional pulmonary device technology announced today that the National Institute for Health and Care Excellence (NICE) in the UK has expanded its guidance on the diagnosis ...
Positive Coverage Policy from Health Care Service Corporation (HCSC) Covers Blue Cross Blue Shield Members in Illinois, Montana, New Mexico, Oklahoma and Texas REDWOOD CITY, Calif., Nov. 02, 2020 ...
Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Pulmonx Corporation (LUNG) (Nasdaq: LUNG) (“Pulmonx”), a global ...
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
The Zephyr Valve Helps COPD/Emphysema Patients Breathe Easier Without the Risk of Major Surgery 1 REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx ...
Jul. 1—MORGANTOWN — A new treatment for emphysema is coming to West Virginia. The Zephyr Valve, a treatment classified a medical breakthrough by the Food and Drug Administration, will be offered by ...
>> HOW ARE YOU FEELING, HOW’S YOUR BREATHING? >> GOOD. EMILY: THAT’S A NEW EXPERIENCE FOR RICHARD WELLS. FOR 15 YEARS, HE HAS STRUGGLED TO BREATHE. >> I JUST COULDN’T DO ANYTHING. COULDN’T DO ANYTHING ...
REDWOOD CITY, Calif. & TOKYO--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback